Shopping Cart 0
Cart Subtotal
USD 0

Eye Socket Implant Market: Current Analysis and Forecast (2021-2027)

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 3500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 4900

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 6860

Details

THE HUMAN EYE IS PROTECTED WITH PHYSIOLOGICAL AND ANATOMICAL BARRIERS. THEY HELP IN BLOCKING THE ENTRY XENOBIOTICS AND LOWER THE BIOAVAILABILITY OF THERAPEUTIC AGENTS. INTERIOR AND POSTERIOR OCULAR DISORDER NEED FREQUENT ADMINISTRATION OF TOPICAL EYE DROP FORMULATION AND INTRAVITREAL INJECTIONS TO MAINTAIN EFFECTIVE TISSUE DRUG LEVELS. EYE SOCKET IMPLANT IS A SOLUTION TO THIS PROBLEM. EYE SOCKET IMPLANT LOADED WITH DRUG CAN RELEASE ACTIVE THERAPEUTIC AGENTS AND UNINTERRUPTEDLY MAINTAIN DRUG CONCENTRATIONS AT THE DESIRED SITE OF ACTION. OTHER FORMS OF EYE SOCKET IMPLANT ARE INTRA-OCULAR LENSES, WHICH HELPS IN INCREASING SHARPNESS OF VISION, THESE LENSES ARE FREQUENTLY INSERTED TO THE PATIENT'S EYE AFTER CATARACT SURGERY. THESE ARE USUALLY TRANSPARENT, TOLERABLE MATERIALS OF AN APPROPRIATE SIZE, POWER, AND SHAPE. EYE SOCKET IMPLANT CAN ALSO BE USED FOR PROSTHETIC PURPOSES. PROSTHETIC EYES ARE AN ARTIFICIALLY MADE SHELL THAT COVERS THE STRUCTURE OF EYE SOCKET. IMPLANTING OF A PROSTHETIC EYE IS CALLED OCULAR PROSTHESIS. DISEASES SUCH AS GLAUCOMA, INFECTION OR EYE TUMOURS CAN LEAD TO REMOVAL OF ONE'S EYE.

BASED ON PRODUCT, THE EYE SOCKET IMPLANT MARKET IS SEGMENTED INTO INTEGRATED, SEMI-INTEGRATED AND NON-INTEGRATED. NON-INTEGRATED IMPLANTS ACCOUNTED FOR A MARKET VALUATION OF USD XX BILLION IN 2020 AND IS EXPECTED TO REACH USD XX BILLION BY THE YEAR 2027, AT A CAGR OF XX% OVER THE ANALYSED PERIOD. POROUS OR NON-POROUS MATERIAL ARE THE MAJORLY USED MATERIAL FOR EYE SOCKET IMPLANT. THE POROUS MATERIAL SEGMENT IS FURTHER DIVIDED INTO NATURAL OR SYNTHETIC. THE POROUS MATERIAL SEGMENT GENERATED REVENUE OF USD XX MILLION IN 2020 AND IS EXPECTED TO GROW AT A CAGR OF XX% DURING THE FORECAST PERIOD TO REACH A MARKET VALUATION OF USD XX MILLION BY 2027F. BASED ON END-USER, THE MARKET IS SEGMENTED INTO HOSPITALS, OPHTHALMOLOGY SURGERY CENTRE, AMBULATORY SURGICAL CENTRE, AND SPECIALTY CLINICS. THE HOSPITALS SEGMENT WAS VALUED AT USD XX BILLION IN 2020 AND IS LIKELY TO REACH USD XX BILLION BY 2027 GROWING AT A CAGR OF XX% FROM 2021-2027.

FOR A BETTER UNDERSTANDING OF THE MARKET, THE REPORT PROVIDES DETAILED ANALYSIS FOR MAJOR REGIONS INCLUDING NORTH AMERICA (UNITED STATES, CANADA, AND REST OF NORTH AMERICA), EUROPE (GERMANY, FRANCE, ITALY, SPAIN, UNITED KINGDOM AND REST OF EUROPE), ASIA-PACIFIC (CHINA, JAPAN, INDIA, AUSTRALIA, AND REST OF APAC), AND REST OF WORLD. NORTH AMERICA CONSTITUTES A MAJOR SHARE OF THE GLOBAL EYE SOCKET IMPLANT MARKET AND GENERATED REVENUE OF USD XX MILLION IN 2020 OWING TO THE PRESENCE OF WELL-ESTABLISHED PLAYERS IN THE REGION, RISING HEALTHCARE INVESTMENT BY THE COMPANIES, ETC. SOME OF THE MAJOR PLAYERS OPERATING IN THE MARKET INCLUDE NOVARTIS AG, JOHNSON AND JOHNSON, PFIZER INC., PORIFEROUS LLC, NOVAMED LTD, NETWORK MEDICAL PRODUCTS LTD., BAUSCH AND LOMB INCORPORATED, STAAR SURGICAL, CARL ZEISS MEDITEC AG, MOCHER GMBH. SEVERAL M&A'S ALONG WITH PARTNERSHIPS HAVE BEEN UNDERTAKEN BY THESE PLAYERS TO BOOST THEIR PRESENCE IN DIFFERENT REGIONS.
READ MORE

Table Of Content

Scope

1 MARKET INTRODUCTION

1.1. MARKET DEFINITIONS

1.2. OBJECTIVE OF THE STUDY

1.3. LIMITATION

1.4. STAKE HOLDERS

1.5. CURRENCY USED IN REPORT

1.6. SCOPE OF THE EYE SOCKET IMPLANTS MARKET STUDY

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. RESEARCH METHODOLOGY FOR THE EYE SOCKET IMPLANTS MARKET

2.1.1. MAIN OBJECTIVE OF THE EYE SOCKET IMPLANTS MARKET

3 INDUSTRY PERFORMANCE

4 EXECUTIVE SUMMARY

5 COVID-19 IMPACT

6 MARKET INSIGHTS BY PRODUCT

6.1. INTEGRATED

6.2. SEMI-INTEGRATED

6.3. NON-INTEGRATED

7 MARKET INSIGHTS BY MATERIAL

7.1. POROUS MATERIAL IMPLANTS

7.1.1. NATURAL

7.1.2 SYNTHETIC

7.2. NON-POROUS MATERIAL IMPLANTS

8 MARKET INSIGHTS BY END-USER

8.1. HOSPITALS

8.2. OPHTHALMOLOGY SURGERY CENTER

8.3. AMBULATORY SURGICAL CENTERS

8.4. SPECIALTY CLINICS

9 MARKET INSIGHTS BY REGION

9.1. NORTH AMERICA EYE SOCKET IMPLANTS MARKET

9.1.1. UNITED STATES OF AMERICA

9.1.2. CANADA

9.1.3. REST OF NORTH AMERICA

9.2 EUROPE EYE SOCKET IMPLANTS MARKET

9.2.1. UNITED KINGDOM

9.2.2. GERMANY

9.2.3. FRANCE

9.2.4. SPAIN

9.2.5. ITALY

9.2.6. REST OF EUROPE

9.3. ASIA-PACIFIC EYE SOCKET IMPLANTS MARKET

9.3.1. CHINA

9.3.2. JAPAN

9.3.3. INDIA

9.3.4. AUSTRALIA

9.3.5. REST OF ASIA-PACIFIC

9.4. REST OF THE WORLD EYE SOCKET IMPLANTS MARKET

10 LEGAL AND REGULATORY FRAMEWORK

11 DEMAND AND SUPPLY SIDE ANALYSIS

11.1. DEMAND SIDE ANALYSIS

11.2. SUPPLY SIDE ANALYSIS

11.2.1. TOP PRODUCT LAUNCHES

11.2.2. TOP BUSINESS PARTNERSHIPS

11.2.3. TOP BUSINESS EXPANSIONS, INVESTMENTS AND DIVESTITURES

11.2.4. TOP MERGER AND ACQUISITIONS

12 VALUE CHAIN ANALYSIS

13 EYE SOCKET IMPLANTS MARKET TRENDS & INSIGHTS

14 EYE SOCKET IMPLANTS MARKET DYNAMICS

14.1. DRIVERS

14.2. CHALLENGES

14.3. IMPACT ANALYSIS

14.4. OPPORTUNITY

15 COMPETITIVE SCENARIO

15.1. EYE SOCKET IMPLANT MARKET SHARE, BY COMPANY 2020

16 COMPANY PROFILED

16.1. AJL OPHTHALMIC SA (ADDITION TECHNOLOGY INC.)

16.2. ALCON

16.3. AUROLAB

16.4. BAUSCH & LOMB

16.5. BVI (PHYSIOL)

16.6. CARL ZEISS

16.7. GULDEN OPHTHALMICS

16.8. JOHNSON & JOHNSON

16.9. MORCHER GMBH

16.10. STAAR SURGICAL

17 DISCLAIMER

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

AJL OPHTHALMIC SA (ADDITION TECHNOLOGY INC.)

ALCON

AUROLAB

BAUSCH & LOMB

BVI (PHYSIOL)

CARL ZEISS

GULDEN OPHTHALMICS

JOHNSON & JOHNSON

MORCHER GMBH

STAAR SURGICAL

Company Profile

Company Profile Title

THE HUMAN EYE IS PROTECTED WITH PHYSIOLOGICAL AND ANATOMICAL BARRIERS. THEY HELP IN BLOCKING THE ENTRY XENOBIOTICS AND LOWER THE BIOAVAILABILITY OF THERAPEUTIC AGENTS. INTERIOR AND POSTERIOR OCULAR DISORDER NEED FREQUENT ADMINISTRATION OF TOPICAL EYE DROP FORMULATION AND INTRAVITREAL INJECTIONS TO MAINTAIN EFFECTIVE TISSUE DRUG LEVELS. EYE SOCKET IMPLANT IS A SOLUTION TO THIS PROBLEM. EYE SOCKET IMPLANT LOADED WITH DRUG CAN RELEASE ACTIVE THERAPEUTIC AGENTS AND UNINTERRUPTEDLY MAINTAIN DRUG CONCENTRATIONS AT THE DESIRED SITE OF ACTION. OTHER FORMS OF EYE SOCKET IMPLANT ARE INTRA-OCULAR LENSES, WHICH HELPS IN INCREASING SHARPNESS OF VISION, THESE LENSES ARE FREQUENTLY INSERTED TO THE PATIENT'S EYE AFTER CATARACT SURGERY. THESE ARE USUALLY TRANSPARENT, TOLERABLE MATERIALS OF AN APPROPRIATE SIZE, POWER, AND SHAPE. EYE SOCKET IMPLANT CAN ALSO BE USED FOR PROSTHETIC PURPOSES. PROSTHETIC EYES ARE AN ARTIFICIALLY MADE SHELL THAT COVERS THE STRUCTURE OF EYE SOCKET. IMPLANTING OF A PROSTHETIC EYE IS CALLED OCULAR PROSTHESIS. DISEASES SUCH AS GLAUCOMA, INFECTION OR EYE TUMOURS CAN LEAD TO REMOVAL OF ONE'S EYE.

BASED ON PRODUCT, THE EYE SOCKET IMPLANT MARKET IS SEGMENTED INTO INTEGRATED, SEMI-INTEGRATED AND NON-INTEGRATED. NON-INTEGRATED IMPLANTS ACCOUNTED FOR A MARKET VALUATION OF USD XX BILLION IN 2020 AND IS EXPECTED TO REACH USD XX BILLION BY THE YEAR 2027, AT A CAGR OF XX% OVER THE ANALYSED PERIOD. POROUS OR NON-POROUS MATERIAL ARE THE MAJORLY USED MATERIAL FOR EYE SOCKET IMPLANT. THE POROUS MATERIAL SEGMENT IS FURTHER DIVIDED INTO NATURAL OR SYNTHETIC. THE POROUS MATERIAL SEGMENT GENERATED REVENUE OF USD XX MILLION IN 2020 AND IS EXPECTED TO GROW AT A CAGR OF XX% DURING THE FORECAST PERIOD TO REACH A MARKET VALUATION OF USD XX MILLION BY 2027F. BASED ON END-USER, THE MARKET IS SEGMENTED INTO HOSPITALS, OPHTHALMOLOGY SURGERY CENTRE, AMBULATORY SURGICAL CENTRE, AND SPECIALTY CLINICS. THE HOSPITALS SEGMENT WAS VALUED AT USD XX BILLION IN 2020 AND IS LIKELY TO REACH USD XX BILLION BY 2027 GROWING AT A CAGR OF XX% FROM 2021-2027.

FOR A BETTER UNDERSTANDING OF THE MARKET, THE REPORT PROVIDES DETAILED ANALYSIS FOR MAJOR REGIONS INCLUDING NORTH AMERICA (UNITED STATES, CANADA, AND REST OF NORTH AMERICA), EUROPE (GERMANY, FRANCE, ITALY, SPAIN, UNITED KINGDOM AND REST OF EUROPE), ASIA-PACIFIC (CHINA, JAPAN, INDIA, AUSTRALIA, AND REST OF APAC), AND REST OF WORLD. NORTH AMERICA CONSTITUTES A MAJOR SHARE OF THE GLOBAL EYE SOCKET IMPLANT MARKET AND GENERATED REVENUE OF USD XX MILLION IN 2020 OWING TO THE PRESENCE OF WELL-ESTABLISHED PLAYERS IN THE REGION, RISING HEALTHCARE INVESTMENT BY THE COMPANIES, ETC. SOME OF THE MAJOR PLAYERS OPERATING IN THE MARKET INCLUDE NOVARTIS AG, JOHNSON AND JOHNSON, PFIZER INC., PORIFEROUS LLC, NOVAMED LTD, NETWORK MEDICAL PRODUCTS LTD., BAUSCH AND LOMB INCORPORATED, STAAR SURGICAL, CARL ZEISS MEDITEC AG, MOCHER GMBH. SEVERAL M&A'S ALONG WITH PARTNERSHIPS HAVE BEEN UNDERTAKEN BY THESE PLAYERS TO BOOST THEIR PRESENCE IN DIFFERENT REGIONS.
READ MORE

Scope

1 MARKET INTRODUCTION

1.1. MARKET DEFINITIONS

1.2. OBJECTIVE OF THE STUDY

1.3. LIMITATION

1.4. STAKE HOLDERS

1.5. CURRENCY USED IN REPORT

1.6. SCOPE OF THE EYE SOCKET IMPLANTS MARKET STUDY

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. RESEARCH METHODOLOGY FOR THE EYE SOCKET IMPLANTS MARKET

2.1.1. MAIN OBJECTIVE OF THE EYE SOCKET IMPLANTS MARKET

3 INDUSTRY PERFORMANCE

4 EXECUTIVE SUMMARY

5 COVID-19 IMPACT

6 MARKET INSIGHTS BY PRODUCT

6.1. INTEGRATED

6.2. SEMI-INTEGRATED

6.3. NON-INTEGRATED

7 MARKET INSIGHTS BY MATERIAL

7.1. POROUS MATERIAL IMPLANTS

7.1.1. NATURAL

7.1.2 SYNTHETIC

7.2. NON-POROUS MATERIAL IMPLANTS

8 MARKET INSIGHTS BY END-USER

8.1. HOSPITALS

8.2. OPHTHALMOLOGY SURGERY CENTER

8.3. AMBULATORY SURGICAL CENTERS

8.4. SPECIALTY CLINICS

9 MARKET INSIGHTS BY REGION

9.1. NORTH AMERICA EYE SOCKET IMPLANTS MARKET

9.1.1. UNITED STATES OF AMERICA

9.1.2. CANADA

9.1.3. REST OF NORTH AMERICA

9.2 EUROPE EYE SOCKET IMPLANTS MARKET

9.2.1. UNITED KINGDOM

9.2.2. GERMANY

9.2.3. FRANCE

9.2.4. SPAIN

9.2.5. ITALY

9.2.6. REST OF EUROPE

9.3. ASIA-PACIFIC EYE SOCKET IMPLANTS MARKET

9.3.1. CHINA

9.3.2. JAPAN

9.3.3. INDIA

9.3.4. AUSTRALIA

9.3.5. REST OF ASIA-PACIFIC

9.4. REST OF THE WORLD EYE SOCKET IMPLANTS MARKET

10 LEGAL AND REGULATORY FRAMEWORK

11 DEMAND AND SUPPLY SIDE ANALYSIS

11.1. DEMAND SIDE ANALYSIS

11.2. SUPPLY SIDE ANALYSIS

11.2.1. TOP PRODUCT LAUNCHES

11.2.2. TOP BUSINESS PARTNERSHIPS

11.2.3. TOP BUSINESS EXPANSIONS, INVESTMENTS AND DIVESTITURES

11.2.4. TOP MERGER AND ACQUISITIONS

12 VALUE CHAIN ANALYSIS

13 EYE SOCKET IMPLANTS MARKET TRENDS & INSIGHTS

14 EYE SOCKET IMPLANTS MARKET DYNAMICS

14.1. DRIVERS

14.2. CHALLENGES

14.3. IMPACT ANALYSIS

14.4. OPPORTUNITY

15 COMPETITIVE SCENARIO

15.1. EYE SOCKET IMPLANT MARKET SHARE, BY COMPANY 2020

16 COMPANY PROFILED

16.1. AJL OPHTHALMIC SA (ADDITION TECHNOLOGY INC.)

16.2. ALCON

16.3. AUROLAB

16.4. BAUSCH & LOMB

16.5. BVI (PHYSIOL)

16.6. CARL ZEISS

16.7. GULDEN OPHTHALMICS

16.8. JOHNSON & JOHNSON

16.9. MORCHER GMBH

16.10. STAAR SURGICAL

17 DISCLAIMER

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

AJL OPHTHALMIC SA (ADDITION TECHNOLOGY INC.)

ALCON

AUROLAB

BAUSCH & LOMB

BVI (PHYSIOL)

CARL ZEISS

GULDEN OPHTHALMICS

JOHNSON & JOHNSON

MORCHER GMBH

STAAR SURGICAL